Evidence map›Paper›PMID 37669274›Full record

ArticlePloS one2023

The burden of ischemic heart disease and the epidemiologic transition in the Eastern Mediterranean Region: 1990-2019.

Masoumeh Sadeghi, Marjan Jamalian, Kamran Mehrabani-Zeinabad, Karam Turk-Adawi, Jacek Kopec, Wael AlMahmeed, Hanan F Abdul Rahim, Hasan Ali Farhan, Wagida Anwar, Yosef Manla and 16 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Effect of gender on spect myocardial perfusion imaging results in Egypt.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 12 countries.

Masoumeh SadeghiCardiovascular Research Institute, Cardiac Rehabilitation Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Marjan JamalianCardiovascular Research Institute, Hypertension Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Kamran Mehrabani-ZeinabadCardiovascular Research Institute, Pediatric Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Karam Turk-AdawiDepartment of Public Health, QU-Health, Qatar University, Doha, Qatar.
Jacek KopecSchool of Population & Public Health, University of British Columbia, Vancouver, Canada.
Wael AlMahmeedHeart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Hanan F Abdul RahimDepartment of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar.
Hasan Ali FarhanScientific Council of Cardiology, Iraqi Board for Medical Specializations. Baghdad Heart Center, Baghdad, Iraq.ORCID 0000-0002-6061-4966
Wagida AnwarFaculty of Medicine, Community Medicine Department, Ain Shams University, Egypt and Armed Forces College of Medicine (AFCM), Cairo, Egypt.
Yosef ManlaHeart and Vascular Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
Ibtihal FadhilEastern Mediterranean NCD Alliance, Alsafat, Kuwait.
Michelle LuiSchool of Population & Public Health, University of British Columbia, Vancouver, Canada.
Hamidreza RoohafzaCardiovascular Research Institute, Interventional Cardiology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Sheikh Mohammed Shariful IslamInstitute for Physical Activity and Nutrition, Deakin University, Melbourne, Australia.ORCID 0000-0001-7926-9368
Kadhim SulaimanNational Heart Center, Royal Hospital, Muscat, Oman.
Nooshin BazarganiDepartment of Cardiology, Dubai Hospital, Dubai, UAE.
George SaadeDepartment of Cardiology, Bellevue Medical Center, Beirut, Lebanon.
Nejat HassenSchool of Population & Public Health, University of British Columbia, Vancouver, Canada.
Amani AlandejaniSchool of Population & Public Health, University of British Columbia, Vancouver, Canada.
Amr AbdinSyrian Cardiovascular Association, Damascus, Syria.
Saira BokhariDepartment of Medicine, Aga Khan University Hospital, Karachi, Pakistan.
Gregory A RothInstitute for Health Metrics and Evaluation, University of Washington, Seattle, United States of America.
Catherine JohnsonInstitute for Health Metrics and Evaluation, University of Washington, Seattle, United States of America.
Benjamin StarkInstitute for Health Metrics and Evaluation, University of Washington, Seattle, United States of America.
Nizal SarrafzadeganSchool of Population & Public Health, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-6828-2169
Ali H MokdadInstitute for Health Metrics and Evaluation, University of Washington, Seattle, United States of America.
Isfahan University of Medical Sciences · IRUniversity of British Columbia · CAUniversity of Washington · USQatar University · QAAga Khan University Hospital · PKAin Shams University · EGAmerican University of Beirut Medical Center · LBBaghdad Medical City · IQDeakin University · AUDubai Hospital · AERoyal Hospital · OMUniversity of Aleppo · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been estimated that in the next decade, IHD prevalence, DALYs and deaths will increase more significantly in EMR than in any other region of the world. This study aims to provide a comprehensive description of the trends in the burden of ischemic heart disease (IHD) across the countries of the Eastern Mediterranean Region (EMR) from 1990 to 2019. Data on IHD prevalence, disability-adjusted life years (DALYs), mortality, DALYs attributable to risk factors, healthcare access and quality index (HAQ), and universal health coverage (UHC) were extracted from the Global Burden of Disease (GBD) database for EMR countries. The data were stratified based on the social demographic index (SDI). Information on cardiac rehabilitation was obtained from publications by the International Council of Cardiovascular Prevention and Rehabilitation (ICCPR), and additional country-specific data were obtained through advanced search methods. Age standardization was performed using the direct method, applying the estimated age structure of the global population from 2019. Uncertainty intervals were calculated through 1000 iterations, and the 2.5th and 97.5th percentiles were derived from these calculations. The age-standardized prevalence of IHD in the EMR increased from 5.0% to 5.5% between 1990 and 2019, while it decreased at the global level. In the EMR, the age-standardized rates of IHD mortality and DALYs decreased by 11.4% and 15.4%, respectively, during the study period, although both rates remained higher than the global rates. The burden of IHD was found to be higher in males compared to females. Bahrain exhibited the highest decrease in age-standardized prevalence (-3.7%), mortality (-65.0%), and DALYs (-69.1%) rates among the EMR countries. Conversely, Oman experienced the highest increase in prevalence (14.5%), while Pakistan had the greatest increase in mortality (30.0%) and DALYs (32.0%) rates. The top three risk factors contributing to IHD DALYs in the EMR in 2019 were high systolic blood pressure, high low-density lipoprotein cholesterol, and particulate matter pollution. The trend analysis over the 29-year period (1990-2019) revealed that high fasting plasma glucose (64.0%) and high body mass index (23.4%) exhibited increasing trends as attributed risk factors for IHD DALYs in the EMR. Our findings indicate an increasing trend in the prevalence of IHD and a decrease in mortality and DALYs in the EMR. These results emphasize the need for well-planned prevention and treatment strategies to address the risk factors associated with IHD. It is crucial for the countries in this region to prioritize the development and implementation of programs focused on health promotion, education, prevention, and medical care.

Indexed as

Cardiac RehabilitationBahrainBody Mass IndexCholesterol, HDLCholesterol, LDLFemaleHumansMaleCholesterol, HDLCholesterol, LDL

Identifiers

PMID37669274
PMCPMC10479892
OpenAlexW4386453646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.